Time Is A Critical Factor in Plasma Collection Post COVID-19 Recovery

Time Is A Critical Factor in Plasma Collection Post COVID-19 Recovery

  • Research Stash
  • News
  • 1.3K

India has adopted plasma therapy in some severely ill COVID-19 patients. While plasma therapy hasn’t yet shown a benefit in randomized trials, some small retrospective studies suggest it may reduce illness severity and reduce hospitalization time.

In a new study, researchers report that antibody levels in the blood of COVID-19 patients drop rapidly during the weeks after their bodies have cleared the virus and symptoms have subsided. If convalescent plasma is ultimately shown to have a clear benefit, the authors concluded, then it needs to be collected during a specific window of time after recovery. However, recovering patients can’t donate blood until at least 14 days after symptoms have subsided, to give the body time to clear viral particles.

“We don’t want to transfuse the virus, just transfuse the antibodies,” said Andrés Finzi, Ph.D., University of Montreal, Canada. “But at the same time, our work shows that the capacity of the plasma to neutralize viral particles is going down during those first weeks,” he said.

The spike protein of SARS-CoV-2 plays a crucial role in helping the virus grab and invade host cells. Antibodies produced by the body’s immune system bind to a part of this protein and block the capacity of this “key” to engage with the host’s cellular “lock”, said Finzi, this prevents the viral particle from infecting a cell host.

In the new longitudinal study, Finzi and his colleagues analyzed blood samples collected at one-month intervals from 31 individuals recovering from COVID-19. They measured levels of immunoglobulins that act against the coronavirus S protein and tested the ability of the antibodies to neutralize the virus.

Previous studies suggest that antibodies against the SARS-CoV-2 spike protein peak 2 or 3 weeks after the onset of symptoms. Findings from an earlier cross-sectional study by Finzi’s group, involving more than 100 patients, suggested that the ability of plasma to neutralize the virus decreased significantly between 3 and 6 weeks after symptom onset.

The researchers observed variation on the level of individual patients but identified a consistent overall signal: The levels of Immunoglobulins G, A, and M that target the binding site decreased between 6 and 10 weeks after symptoms began. During the same period, the ability of the antibodies to neutralize the virus similarly fell.

Finzi’s group has continued to study blood samples from the patients. Understanding how the levels of antibodies change over time. “It is critical not only for optimizing the use of convalescent plasma but also for understanding vaccine efficacy and whether or not previously infected people are at risk of re-infection,” said Finzi.

The research has been published in the mBio, an open-access journal of the American Society for Microbiology.

If you liked this article, then please subscribe to our YouTube Channel for the latest Science & Tech news. You can also find us on Twitter & Facebook

Rate

The spike protein of SARS-CoV-2 plays a crucial role in helping the virus grab and invade host cells. Antibodies produced by the body’s immune system bind to a part of this protein and block the capacity of this “key” to engage with the host’s cellular “lock”, said Finzi, this prevents the viral particle from infecting a cell host.

In the new longitudinal study, Finzi and his colleagues analyzed blood samples collected at one-month intervals from 31 individuals recovering from COVID-19. They measured levels of immunoglobulins that act against the coronavirus S protein and tested the ability of the antibodies to neutralize the virus.

Previous studies suggest that antibodies against the SARS-CoV-2 spike protein peak 2 or 3 weeks after the onset of symptoms. Findings from an earlier cross-sectional study by Finzi’s group, involving more than 100 patients, suggested that the ability of plasma to neutralize the virus decreased significantly between 3 and 6 weeks after symptom onset.

The researchers observed variation on the level of individual patients but identified a consistent overall signal: The levels of Immunoglobulins G, A, and M that target the binding site decreased between 6 and 10 weeks after symptoms began. During the same period, the ability of the antibodies to neutralize the virus similarly fell.

Finzi’s group has continued to study blood samples from the patients. Understanding how the levels of antibodies change over time. “It is critical not only for optimizing the use of convalescent plasma but also for understanding vaccine efficacy and whether or not previously infected people are at risk of re-infection,” said Finzi.

The research has been published in the mBio, an open-access journal of the American Society for Microbiology.

If you liked this article, then please subscribe to our YouTube Channel for the latest Science & Tech news. You can also find us on Twitter & Facebook

" }
The Nobel Prize in Physiology or Medicine 2019 - How Cells Adapt to Changes in Oxygen Levels

The Nobel Prize in Physiology or Medicine 2019 Awarded for The Discovery of How Cells Sense Oxygen

This year’s Nobel Laureates revealed the mechanism for one of life’s most essential adaptive processes. They established the basis for our understanding of how oxygen levels affect cellular metabolism and physiological function. Their discoveries have also paved the way for promising new strategies to fight anemia, cancer and many other diseases

  • News
  • 2.6K
Read more
Wheat Varieties Susceptible To New Strains Of Yellow Rust Fungus

Wheat Varieties Susceptible To New Strains Of Yellow Rust Fungus

Agriculture scientists have cautioned about likely spread of extremely virulent strains of fungus that causes yellow rust in wheat to which currently used wheat cultivars show high susceptibility

  • News
  • 1.6K
Read more
A Path-Breaking Research for Safer Pregnancy Drugs

A Path-Breaking Research for Safer Pregnancy Drugs

Prof Achalkumar and Prof. Yasuhiro Ishida from RIKEN, Wako-shi campus, Japan, have developed a simple and novel method to separate chiral enantiomers.

  • News
  • 1.4K
Read more

Internet is huge! Help us find great content

Newsletter

Never miss a thing! Sign up for our newsletter to stay updated.

About

Research Stash is a curated collection of tools and News for S.T.E.M researchers

Have any questions or want to partner with us? Reach us at hello@researchstash.com

Navigation

Submit